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a b s t r a c t
High-fat diet (HFD) and inﬂammation are the key contributors to insulin resistance and type 2 diabetes
(T2D). Previous study shows fatty acid-induced accumulation of damaged, reactive oxygen species
(ROS)-generating mitochondria, and this in turn activates the NLRP3 inﬂammasome interference with
insulin signaling. Our previous research shows NLRP3 inﬂammasome activation signal originates from
defects in autophagy. Yet how the fatty acid related to mitophagy alteration leads to the activation of
NLRP3-ASC inﬂammasome has not been considered. Here we demonstrated that palmitate (PA) induced
mitophagy deﬁciency, leading to damaged mitochondrion as characterized by mito-ROS production and
loss of membrane potential. Antioxidant APDC or Ca2þ signaling inhibitor Nifedipine blocked PA-
induced NLRP3 inﬂammasome activation. Further, we provided evidences that PA reduced the
expression of Ras homolog enriched in brain (Rheb) and disrupted Rheb recruitment to the mitochon-
drial outer membrane. In addition, sustained PA caused disassociation of kinesin family member 5B
(KIF5B) from binding with mitochondria via Ca2þ-dependent effects. Disruption of Rheb and KIF5B
interaction with mitochondria blocked mitochondrial degradation along with IL-1β dependent insulin
resistance, which was majorly attenuated by Rheb/KIF5B overexpression. In a consequence, defective
mitophagy led to the accumulation of damaged-ROS-generating mitochondria, down pathway of NLRP3-
ASC-Caspase 1 activation, and subsequently, insulin resistance. These ﬁndings provide insights into the
association of inﬂammation, mitophagy and T2D.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
The prevalence of T2D has increased markedly both in devel-
oping and developed countries. It is a low-grade inﬂammatory
disease with insulin resistance caused by glucolipotoxicity in islets
of diabetic patients and animal models. The discovery of NOD-like
receptors (NLRs) as essential components of the immune system
triggered signiﬁcant interest in the study of their contributions to
be a key regulator of glucose and insulin homeostasis [1–3]. This
association between metabolic stress and inﬂammation suggests a
causal link, which is now supported by experimental data from
in vitro and in vivo. in vitro, palmitic acid (PA) induces proin-
ﬂammatory responses in many cell types such as macrophage, rat
insulinoma line, and islets [4–6]. PA involves in the production of
reactive oxygen species (ROS), which in turn induces stress
kinases. ROS may also lead to the formation of NLRP3 inﬂamma-
somes, which activates the IL-1 system. in vivo, several studies
using genetically modiﬁed mice that lack inﬂammasome compo-
nents NLRP3, ASC, and Caspase-1 displaying improved insulin
sensitivity provides initial evidence that activation of the NLRP3
inﬂammasome is a key mechanism that induces metabolic inﬂam-
mation and insulin resistance [2,7–9]. Taken together, previous
research data suggests that HFG triggers aberrant activation of the
NLRP3-ASC-Caspase 1 immune system in metabolic disorders, and
the mitochondrion appears to be the common pathway for these
events.
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Mitochondria in beta cells plays an essential role by metaboliz-
ing nutrients and generating signals required for both triggering
and amplifying pathways of insulin secretion respond to changes
in extra-cellular nutrients. Sustained HFD-induced stress leads to
damaged mitochondria within cells [10]. The elimination of
cytosolic components inside cells such as damaged organelles
can occur through autophagy. Mitophagy is a speciﬁc form of
autophagy in which damaged mitochondria are speciﬁcally tar-
geted for autophagic degradation by the lysosomes to dampen the
proinﬂammatory activation [11,12]. The premise that mitophagy
dysfunction plays a main role in HFD-induced NLRP3 dependent
proinﬂammatory responses and later on T2D initiates a growing
interest on this topic in order to validate the hypothesis [13]. Our
previous research showed that PA induced NLRP3 dependent
proinﬂammatory responses dependent of autophagy activation
status [5]. However, how the mitophagy machinery responds to
metabolic stress imposed by PA linking to the NLRP3-ASC-Caspase
1 proinﬂammatory response is far from clear.
In this report, we demonstrated that PA-induced disruption of
kinesin family member 5B (KIF5B)-mediated mitochondrial moti-
lity and loss of the Ras homolog enriched in brain (Rheb)-
dependent mitophagy resulted in defective mitophagy, leading
to the accumulation of damaged-mitochondria-producing-ROS,
and down pathway of NLRP3 dependent proinﬂammatory
responses, and subsequently, caused IL-1β dependent insulin
resistance. Our results therefore provided a possible mechanism
for mitophagy deﬁciency under PA stress in T2D.
Materials and methods
Cell culture and stimulation
Rat Insulinoma INS-1E cells were grown in RPMI 1640 medium as described
previously [48]. Bone marrow-derived macrophages (BMMs) were generated in the
presence of L-929 conditional medium and granulocyte-macrophage colony-
stimulating factor. After pretreatment with ultrapure lipopolysaccharide (LPS)
(200 ng/ml) for 3 h, BMMs were stimulated with PA-BSA (500 μM) for 24 h as
indicated. Where indicated, chemical inhibitors were added 30 min before cell
stimulation (2.5 h after LPS priming). Supernatant and cell lysate were collected for
ELISA and immunoblot analysis.
PA-BSA solution preparation
Sodium PA was dissolved in 95% ethanol at 60 1C to yield a
stock concentration of 10 mM and kept at 20 1C. Nitrogen gas
was used to completely remove ethanol from PA stock solution. PA
was then conjugated with fatty acid-free BSA at a 3:1 molar ratio.
Cell transfection
Islets or BMMs were transfected as appropriate described in the
text with Lipofectamine 2000 reagent according to the manufac-
turer’s suggested protocol. In experiments studying caspase inhi-
bition in PA-induced inﬂammasome activation, BMMs were
transfected with siNLRP3. The transfection efﬁciency for islets
and BMMs was 80% by jetPEI kits (Polyplus). In the experiments
studying the mitophagy deﬁciency in IL-1β dependent insulin
secretion, islets were transfected with siRheb or siKIF5B or siAtg7
or PCMV-GFP-Rheb or PCMV-GFP-KIF5B as appropriately
described in the text.
Confocal microscopy
Fixed and permeabilized BMMs or INS-1E or islets were used
for confocal microscopy. Cells were grown and transfected as
described above on one thickness 2-well Lab-Tek chambered cover
glass. After 24 h, confocal microscopy of live cells was performed
by incubation with 20 ng/ml of a mitochondrion-speciﬁc dye and/
or 1–3 M staurosporine as indicated in individual experiments.
Images were collected on an LSM 410 microscope with a 401.2 NA
Apochromat objective. 568 nm lines of a krypton/argon laser were
used for ﬂuorescence excitation of Mitotracker red CMXRos. For
immunoﬂuorescent labeling, the cells were washed with PBS
followed by ﬁxation with 2% paraformaldehyde and permeabiliza-
tion with 0.04% saponin. The ﬁxed cells were blocked with normal
goat serum, probed with mouse anti-Rheb or KIF5B monoclonal
antibodies and stained with Texas red-conjugated goat anti-mouse
IgG antibodies. The cover glasses ﬁnally were washed, mounted,
and examined using the confocal laser microscope.
ELISA
Cytokines in culture supernatants were measured with
ELISA kits.
Western blot analysis
Cell lysates were separated by electrophoresis prior to transfer
to PVDF membranes. The membranes were then probed with
interest antibody and immunoreactive bands were detected by
chemiluminescence. Images were captured and data were ana-
lyzed using a BioRad ChemiDoc™ XRS þ imaging system. Data
were normalized relative to actin. The following primary anti-
bodies were used for Western blots and immunostaining: rabbit
anti-LC3 (Sigma, L8918); Rat monoclonal to LAMP2 (Abcam,
ab13524); anti-β actin antibody (Abcam, ab3280); rabbit polyclo-
nal anti-Atg7 (Cell Signaling Technology, 2631); Anti-IL-1β anti-
body (Abcam, ab2105); Anti-IL6 antibody (Abcam, ab6672); Anti-
MCP1 antibody (Abcam, ab9669); Anti-TNF alpha antibody
(Abcam, ab9635); guinea pig polyclonal anti-p62 (ProGen, GP62-
N); anti-Rheb(Abcam, ab2587); anti-Tom20 (SantaCruz, sc-17764);
anti-calregulin (SantaCruz, sc-6468-R); anti-Gapdh (Abcam,
ab9483); anti-Golgi 58 (Abcam, ab27043); Alexa Fluor-
conjugated antibodies (Molecular probes, A21057, A21076,
A21096) were used as secondary antibodies. Data for LC3 Western
blot analysis was obtained in the presence of an autophagic ﬂux
inhibitor baﬁlomycin (10 nM) to exclude the possibility that
defective autophagy/inhibited ﬂux increased LC3-II.
Mitochondrial isolation
Mitochondria were isolated using mitochondrial isolation kit
according to the manufacturer’s instructions (Pierce). Brieﬂy, cells
were homogenized in a dounce homogenizer and then centrifuged
at 750gfor 10 min at 4 1C. The supernatant was further centrifuged
at 12,000g for 15 min at 4 1C. The pellet was then washed and kept
as the mitochondrial fraction. The supernatant was further cen-
trifuged at 100,000gfor 1 h at 4 1C and designated as the cytosolic
fraction.
Mitochondrial morphology
Cells were grown on poly-d-lysine coated glass coverslips.
Mitochondria were labeled with Mitotracker Red (50 nM, Invitro-
gen) at 37 1C for 30 min and ﬁxed with 4% paraformaldehyde
according to the manual’s instructions. Coverslips were subse-
quently mounted with Prolong Gold Antifade Reagent with DAPI
(Invitrogen). Fluorescence images were captured at room tem-
perature using a camera mounted to an inverted epiﬂuorescence
microscope. Overall contrast and brightness of acquired images
were adjusted using Adobe Photoshop CS6.
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Detection of reactive species
Treated islets were washed in PBS and placed in PBS containing
10 mM 6-carboxy-20,70-dichlorodihydroﬂuorescein diacetate (DHR),
di(acetoxymethyl ester) for 30 min at 37 1C. Following a PBS wash
and re-incubation in PBS for 1 h at 37 1C, 10 mMHydrogen Peroxide
(H2O2) for 2 h was used as a positive control. Fluorescence was
measured on a SpectraMax M5 plate reader; an emission wave-
length 480 nm; excitation wavelength 530 nm.
Islet insulin secretion and insulin content measurements
Before experiments, islets were cultured for 1 h in RPMI-1640
medium. Isolated islets were distributed into 12-well plates (6
islets/well in triplicates) and incubated for 2 h in 1 ml RPMI
complete medium containing 3 mM glucose. After pretreatment
with ultrapure LPS for 3 h, they were then washed and preincu-
bated for 40 min at 37 1C in 1 ml Krebs-Ringer bicarbonate buffer
containing 10 mM HEPES (KRBH; pH 7.4), 0.5% defatted BSA, and
3 mM glucose plus 0.4 mM PA in the presence of Rheb or KIF5B or
siControl or siRheb or siKIF5B. The islets were then preincubated
for 45 min at 37 1C in 0.5 ml Krebs-Ringer bicarbonate buffer
containing 16.7 mM glucose. Supernatant was collected and cells
were lysed by 0.15% HCl. Secreted insulin and cellular insulin
content was monitored by RIA using the rat insulin RIA kit
(Millipore). Insulin secretion index (16.87 mmol/l GSIS over
3 mmol/l GSIS) was calculated. Total intracellular insulin content
was extracted by the acid/ethanol method. Brieﬂy, cells were
incubated in 1% hydrochloric acid alcohol (ethanol/H2O/HCl,
14:57:3) overnight at 4 1C. The insulin in the supernatant was
detected by RIA (Linco, Research, St. Charles, MO), and normalized
to total protein content as described previously [49].
Flow cytometry
MitoSOX, MitoTracker Green and Red, and DCFDA staining were
done according to manufacturer’s instructions (Invitrogen). Data
were acquired with a FACSCalibur ﬂow cytometer (BD Biosciences).
Statistics
The data are presented as the mean 7 SD of three independent
experiments unless otherwise noted. Differences between means
were analyzed using either one-way or two-way ANOVA followed by
Newman–Keuls post-hoc testing for pair-wise comparison using
SPSS. The null hypothesis was rejected when the p-value o 0.05.
Results
Sustained PA þ LPS blocks mitochondrial degradation along with proinﬂammatory
responses
PA is one of the most abundant saturated fatty acids in plasma and is substantially
elevated following HFD. Our previous research demonstrated that 0.5 mM PA induced
autophagy without causing necrosis cell death in INS-1 cells [5], and data from other
groups showed that exposing cells to lipopolysaccharide (LPS) induced the transcrip-
tion and translation of pro-IL-1β and pro-IL-18 [14], and autophagy [15] in macro-
phages. Exposing cells to LPS and then to PA conjugated to fatty acid-free medium
induced NLRP3-ASC-Caspase 1 proinﬂammatory responses [4]. Based on this, we
treated LPS-primed macrophages with 0.5 mM PA for examining the relationship
between mitophagy and proinﬂammatory responses. As showed in Fig. 1, PA induced
IL-1β and IL-18 secretion (Fig. 1A and B) (***, p o 0.001). In contrast to IL-1β
production, the secretion of IL-6 or TNF-α, which depended on Toll-like receptor
signaling only, was not signiﬁcantly increased by PA (p ¼ 0.172; Fig. 1C and D),
indicating speciﬁcity of the PA effect on cytokines production. To investigate whether
the PA effect on the proinﬂammatory responses was driven by mitophagy dysfunction,
we ﬁrst measured mitochondrial proteins degradation in LPS-primed macrophages at
0, 24 h treatment by 0.5 mM PA. We examined the rate of protein degradation by
treating macrophage cells with the protein synthesis inhibitor, cycloheximide (CHX).
As a result, cells with LPS demonstrated a higher rate of mitochondrial protein
degradation compared to LPS þ 0.5 mM PA. Effect of CHX treatment on protein levels
of other cellular compartments such as Golgi (Golgi-58), lysosome (Lamp2), endo-
plasmic reticulum (calregulin), or cytosol (Gapdh, Actin) were independent of PA
effects (*, p o 0.05; Fig. 1E) suggesting that solely mitochondrial protein degradation
rate was impacted under PA stress.
Inhibition of mitochondrial protein degradation was due to
mitophagy deﬁciency dependent of Ca2þ
We proposed that this blockage of mitochondrial proteins degra-
dation was due to defective mitophagy. To test this, we examined
mitophagy using a combination of immunoblot, microscopy, and
pharmacological inhibition analyses. First, we analyzed the proteo-
lytic conversion of the microtubule-associated protein light chain 3
(LC3-I) into the LC3-II isoform, which was conjugated to phosphati-
dylethanolamine and targeted to autophagic membranes upon the
induction of autophagy. We found that the activation of autophagy
was inhibited by PA in macrophage characterized by reduction of
LC3II/LC3I, Lamp2 and elevation of P62 after 24 h of incubation
LPS þ PA in contrast to the control (Fig. 2A). These results were
further conﬁrmed by quantiﬁcation of LC3II/Actin demonstrated in
the right panel (**, p o 0.01; Fig. 2A) and immunoﬂuorescence
staining of LC3II, Lamp2 and P62 in LPS þ PA group compared with
LPS group (Fig. 2B). To test whether the mitophagic deﬁciency was
responsible for the accumulation of mitochondrial proteins upon
LPS þ PA treatment, we analyzed the effect of autophagic inhibition
Fig. 1. PA activates pro-inﬂammatory cytokines expression. (A–C) ELISA for IL-1β
(A), IL-18 (B), and IL-6 (C), and TNF-α (D) in supernatants of LPS primed BMMs
stimulated with PA. (E) Protein degradation rates were measured in macrophage
cells grown under LPS and LPS þ 0.5 mM PA conditions at 0 and 24 h of treatment
with 10 mg/ml cycloheximide (CHX). Level of the mitochondrial proteins was
analyzed using antibodies against SDHA subunit of complex II (CII), ATP synthase
(CV), porin, and Tom20. Golgi apparatus, cytosol, lysosomes, and endoplasmic
reticulum were analyzed using Golgi58, Gapdh, Lamp2, and calregulin (calreg)
antibodies. Quantiﬁcation of protein level after 24 h CHX treatment on macrophage
cells was showed in down panel. Black bars are LPS, and gray bars are in
LPS þ 0.5 mM PA condition. Values are percentage of respective protein amount
at t ¼ 0 (n ¼ 3). Dashed line represents value at t ¼ 0 and normalized to 100% for
each protein. *p o 0.05, ***p o 0.001. Data are presented as mean 7 SD.
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on the mitochondrial degradation. Inhibition of autophagic/lysoso-
mal degradation using protease inhibitors PepA/E64D or by silencing
the autophagic protein 7 (Atg7) hampered mitochondrial degrada-
tion (Fig. 2C and D). We assumed that inhibition of mitophagy led to
the accumulation of ROS-producing damaged mitochondria depen-
dent of Ca2þ , and as a consequence, to the activation of the
inﬂammasome. To test this, we treated BMMs with antioxidant
APDC and Ca2þ signaling inhibitor Nifedipine. As expected, inhibi-
tion of mitophagy by PA resulted in increased concentrations of
mitochondrial ROS (*, p o 0.05, Fig. 2E, up) and PA -induced ROS
generation was paralleled by augmented secretion of IL-1β upon
mitophagy inhibition (Fig. 1A), which was blocked by the antioxidant
APDC or Ca2þ signaling inhibitor Nifedipine (**, p o 0.01,
Fig. 2E, down).
PA-induced mitophagy deﬁciency responsible for damaged
mitochondrion-producing-mtROS mediated NLRP3 dependent
proinﬂammatory responses
Caspase-1 is one of cysteine proteases that initiate or execute
cellular programs, leading to inﬂammation or cell death. Its
catalytic activity is tightly regulated by signal-dependent auto-
activation within the NLRP3 inﬂammasome that mediates caspase-
1-dependent processing of IL-1β. To examine the role of NLRP3
inﬂammasome components in the activation of caspase-1 caused
by mitophagy inhibition, NLRP3 in macrophage cells was depleted
by siRNA. Compared to non-target siRNA control, protein levels of
NLRP3 knockdown cells were totally inhibited (Fig. 3A). NLRP3 and
nontarget control knockdown cells were then challenged with
additional treatments, and caspase-1 activation was revealed by
the appearance of caspase-1 and IL-1β in Western blots. When
compared to non-target control cell group, depletion of NLRP3
caused distinct reduction for IL-1β in (0.5 mM PA þ LPSþsiNLRP3)
group (Fig. 3B). Concomitantly, distinct reduction of caspase-1
levels was also observed (Fig. 3C). Taken together, the results
showed that NLRP3 was required for mitophagy-deﬁciency-
induced caspase-1 activation and IL-1β processing in macrophage
cells. To investigate PA-induced mitophagy deﬁciency induced
damaged mitochondrion-producing ROS, we measured mito-ROS
production by three types of mitochondria-speciﬁc labels that
distinguish respiring (Mitotracker deep red), total (Mitotracker
green) and ROS-generating mitochondria (MitoSOX). We found
that PA stress resulted in robust ROS production and loss of
mitochondrial membrane potential (Fig. 3D and E), and these
efforts were blocked by ROS inhibitor APDC or Ca2þ signaling
inhibitor Nifedipine. Because these processes were required for
NLRP3 inﬂammasome activation, these ﬁndings suggested that the
critical role of Ca2þ signaling, at least during PA stimulation, was
to mediate mitochondrial damage.
Rheb decreased expression and translocation from the mitochondria
contributed to PA-induced mitophagy deﬁciency
Previous research showed that small GTPase Rheb was
recruited to the mitochondrial outer membrane to regulate mito-
chondrial energetic status-induced mitophagy [16]. To test
whether Rheb participated in the PA-induced mitophagy deﬁ-
ciency, we analyzed the effect of PA on Rheb expression. As shown
in Fig. 4A, the decreased expression of Rheb over 48 h in cells
grown with PA was concomitant with the decreased activation of
LC3. This was further conﬁrmed by immunostaining analysis in
groups treated with LPS and LPS þ PA (Fig. 4B). Then we
Fig. 2. PA blocked proper mitophagy activation in macrophage cells. (A) PA
stimulated autophagy activation associated proteins LC3II/LC3I, P62, Lamp2, and
CTSB expression were analyzed by immunoblotting, β-actin as a control; analysis of
Lamp2, LC3II, and P62 levels from macrophage cells were on the right panel (*,
p o 0.05; **, p o 0.01). (B) Immunoﬂuorescence staining of PA stimulated
autophagy activation associated proteins Lamp2, LC3II, and P62 in macrophage
cells under LPS and LPS þ PA treatment. (C and D) Effect of autophagy inhibition on
mitochondrial degradation assayed by treatment protease inhibitors, pepstatin/
E64D (C) or by ATG7 silencing (D). (E) PA induced increased concentrations of mito-
ROS detected by dichlorodihydroﬂuorescein (DHR) and was blocked by ROS
antioxidant APDC or Ca2þ signaling inhibitor nifedipine (*, p o 0.05, up). PA-
induced augmented secretion of IL-1β was blocked by the antioxidant APDC or
nifedipine. Data are presented as mean 7 SD (**, p o 0.01, down).
Fig. 3. NLRP3 knockdown blocked mitophagy deﬁciency induced proinﬂammatory
responses. (A) Macrophage cells were stably transfected with siRNAs that targeted
NLRP3, and protein levels of NLRP3 knockdown cells were analyzed by Western
blot analysis. NLRP3, or non-target control (siRNA Ctrl) knockdown cells were
treated with 0.5 mM PA þ LPS. (B) Secreted IL-1β and (C) activated caspase-1 were
examined by Western blot analysis. (D) and (E) Macrophage cells were stimulated
with LPS, LPS þ 0.5 mM PA, LPS þ PA þ APDC, and LPS þ PAþNifedipine for 6 h
and then stained with Mitotracker green and Mitotracker deep red (D) or MitoSOX
(E) for 30 min and analyzed by ﬂow cytometry.
S. Yang et al. / Redox Biology 3 (2014) 63–7166
investigated PA effect on Rheb distribution within INS-1E cells, the
co-localization of Rheb with Mitotracker was observed using
confocal microscopy. Under non-PA condition, the much larger
size of localization of Rheb was found to localize to mitochondrial
structure and distribute throughout cytoplasm of INS-1E cell
(Fig. 4C). The promoting translocation of Rheb from the mitochon-
dria in the presence of PA was further conﬁrmed by Western blot;
Hsp60 was a loading control. The ratio of Rheb-cytosol/Hsp60 or
Rheb-mitochondria/Hsp60 was shown in Fig. 4D. The cytosolic
concentration of Rheb (Rheb-cytosol) was markedly higher in the
group treated PA while Rheb-mitochondria concentration was
signiﬁcantly decreased in PA compared with a group treated by
LPS (**, p o 0.01; Fig. 4D). Given that Rheb is known to be
essential for Rheb-dependent mitophagy contributes to the main-
tenance of optimal mitochondrial energy production, loss of this
Rheb-dependent mitophagy damages mitochondria under sus-
tained PA stress and may initiate and integrate inﬂammatory
responses.
PA-induced disassociation of KIF5B from outer membrane of
mitochondria contributed to mitophagy deﬁciency
Previous research along with our unpublished data shows that
the protein Miro1 links mitochondria to KIF5B motor proteins,
allowing mitochondria to move along microtubules [17]. This
linkage is inhibited by micromolar levels of Ca2þ binding to Miro1.
Exposure to the PA has been linked to ROS-induced mitochondrial
Ca2þ overload and damage [18]. To test whether the PA-induced
rise of Ca2þ played efforts on KIF5B, the distribution of the KIF5B
within macrophage cells was analyzed. The co-localization of
KIF5B with the mitochondria was observed in the absence/pre-
sence of the PA. Using confocal microscopy to examine the
localization of KIF5B and Mitotracker in BMMs, we found that
before exposure to PA, KIF5B and mitochondria showed diffused
patterns in the cytosol that closely colocalized. After exposure to
PA, they accumulated in the nucleus with partly overlap in their
distribution (Fig. 5A). The promoting translocation of KIF5B from
the mitochondria was further conﬁrmed by Western blot (Fig. 5B);
Hsp60 was a loading control. The ratio of KIF5B-cytosol/Hsp60 or
KIF5B-mitochondria/Hsp60 was shown on the lower panel. The
cytosolic concentration of KIF5B (KIF5B-cytosol) was markedly
higher in group treated with PA than group in the presence of LPS
alone. KIF5B-mitochondria concentration was signiﬁcantly
decreased in state of both PA and LPS compared with the group
treated with either PA or LPS (**, p o 0.01; Fig. 5B). Given that
KIF5B is known to be essential for mitochondrial transport in
mammalian cells, loss of this KIF5B-dependent transport pathway
has been showed to be involved in mitochondrial fragmentation
and following depletion of mitochondria in neurons [19].
Overexpression of KIF5B or Rheb rescued glucose-stimulated insulin
secretion impairment in rat islets
To determine the effect of KIF5B or Rheb on the insulin
secretion function in rat islets, the insulin secretion of cells under
Fig. 4. Rheb participated in the PA-induced mitophagy deﬁciency. (A) The decrease
expression of rheb over 48 h in cells grown in PA was concomitant with the
decrease activation of LC3 by immunostaining analysis in groups treated with LPS
and LPS þ PA respectively. (B) The co-localization of rheb with LC3II was observed
using confocal microscopy in groups treated with LPS and LPS þ PA respectively.
(C) The co-localization of rheb with Mitotracker was observed using confocal
microscopy. Rheb were disassociated from mitochondria and distributed through-
out cytoplasm of INS-1E cell in presence of PA. (D) The promoting translocation of
rheb from the mitochondria in the presence of PA was further conﬁrmed by
Western blot; Hsp60 was a loading control. The ratio of rheb-cytosol/Hsp60 or
rheb-mitochondria/Hsp60 was showed on the right panel. Data are expressed as
the mean 7 S.D. (**, p o 0.01; Fig. 4D) (n ¼ 6).
Fig 5. Ca2þ-mediated disassociation of KIF5B from outer membrane of mitochon-
dria under PA stress. (A) The distribution of the KIF5B within macrophage cells
primed with LPS was analyzed using confocal microscopy in the absence/presence
of the PA. (B) The promoting translocation of KIF5B from the mitochondria was
further conﬁrmed by Western blot; Hsp60 was a loading control. The ratio of
KIF5B-cytosol/Hsp60 or KIF5B-mitochondria/Hsp60 were showed on the right
panel. Data are expressed as the mean 7 S.D. (*, p o 0.05; **, p o 0.01) (n ¼ 6).
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Fig. 6. The effect of expression level of KIF5B or rheb on the insulin secretion function in rat islets. After equilibration at 3.3 mM glucose, islets cells were stimulated with high
glucose (16.7 mM) for 1 h (A). The glucose-stimulated insulin secretion in islets cells was measured by RIA, and then the insulin secretion index was calculated (insulin release at high
glucose/insulin release at basal glucose) in control, LPS, LPS þ PA, LPS þ PAþsiRheb, LPS þ PA þ rheb, LPS þ PA þ siKIF5B, LPS þ PA þ KIF5B groups (**, p o 0.01) (n ¼ 6). (B) The
insulin secretion in islets cells in response to 3.0 and 16.7 mM glucose stimulation was examined at above-mentioned groups (*, p o 0.05; **, p o 0.01) (n ¼ 6). (C) Total insulin
content in islets cells was extracted by the acid/ethanol method and detected using an RIA kit. Data are expressed as the mean 7 S.D. (error bars) (**, p o 0.01) (n ¼ 6).
(D) Rheb/KIF5B and insulin partially co-localize following treated by LPS þ PA in islets. Confocal microscopy of islets primed with LPS for 2 h and stimulated with/without PA, and
immunostained for rheb/KIF5B and insulin. Single and merged images from representative cells are shown. Scale bars shown are 10 μM. (E) A proposal mechanism of PA induced
Ca2þ-mediated mitophagy deﬁciency, leading to NLRP3 dependent proinﬂammatory responses and subsequently, insulin resistance. PA induced rise of Ca2þ concentration targeted
KIF5B and rheb, the disruption of KIF5B-mediated mitochondrial motility and loss of the rheb-dependent mitophagy resulted in defective mitophagy, leading to the accumulation of
damaged-mitochondria-producing-ROS, and down pathway of NLRP3 dependent IL-1β and IL-18 production, and subsequently, caused IL-1β dependent insulin resistance.
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different treatments was measured by a RIA kit and then insulin
secretion indexes were calculated. In the presence of 16.7 mM
glucose, the insulin release in rats islet exposed to LPS þ PA group
was markedly reduced compared with control group to LPS (*,
p o 0.05, **, p o 0.01; Fig. 6A and B), and this effort was rescued
by KIF5B or Rheb overexpression. There was a similar insulin
release between PA þ LPSþsiRheb group and PA þ LPSþsiKIF5B,
but these groups showed a signiﬁcantly lower insulin secretion
comparedwith control group (**, p o 0.01, Fig. 6A and B). LPS þ PA
GSIS of high glucose (16.7 mM glucose) was markedly decreased
(*, p o 0.05, Fig. 6B) compared with control. In PA þ LPSþsiRheb
and PA þ LPSþsiKIF5B treated groups, the GSIS in rat islet cells
was severely decreased compared with control (**, p o 0.01,
Fig. 6B) while there was no difference between LPS þ PA þ Rheb/
KIF5B and control group. These results suggested that KIF5B or
Rheb inhibition was deleterious for impairing GSIS, and this effort
could be attenuated by Rheb or KIF5B overexpression in rat islet
cells. To further determine the toxic effects of KIF5 or Rheb, we
next investigated. After exposure for 24 h, the groups treated with
PA þ LPS and PA þ LPSþsiRheb or siKIF5B robustly reduced the
total insulin content in rat islet cells by 35.6%, 39.6% and 39.5%
compared with control group (0 mM PA) (Fig. 6C) (**, p o 0.01)
respectively. Rheb or KIF5B overexpression rescued this effort,
suggesting that rat islet cells were damaged by the inhibition
expression of KIF5B or Rheb. To conﬁrm the PA-induced IL-1β
dependent insulin resistance, the co-localization of Rheb/KIF5B
and insulin was observed under immunostaining. LPS group
showed larger beta-cell size, highly expressed, and diffusely
distributed Rheb/KIF5B and insulin throughout the cytoplasm.
When cells were under PA stress, the decreased expression of
both Rheb/KIF5B and insulin was distributed near nuclear
(Fig. 6D). Thus, Rheb and KIF5B appear to be important for the
mitophagy machinery in response to metabolic stress linking to
the IL-1β dependent insulin resistance. Hereby, schematic
mechanism to explain the data: sustained PA induced Ca2þ-
dependent effect disrupted Rheb and KIF5B interaction with
mitochondria. Defective mitophagy led to the accumulation of
damaged-ROS-generating mitochondria, down the pathway of
NLRP3 dependent proinﬂammatory responses, and subsequently,
insulin resistance (Fig. 6E).
Discussion
Over the last decades, substantial progress has been made in
deﬁning the physiological function of mitochondria in controlling
insulin action and the potential defects that lead to insulin
resistance and later on T2D. Mitophagy is a highly conserved
cellular pathway designed to degrade damaged mitochondria
during times of metabolic stress. It is also an important part of
immune cell function and shapes subsequent immune responses
under HFD-induced NLRP3 dependent proinﬂammatory activation
[20,21]. The purpose of present study is to deﬁne the role of
mitophagy in the PA-induced NLRP3 proinﬂammatory responses
and insulin resistance. Our ﬁndings showed that mitophagy
deﬁciency driven by malfunction of Rheb and KIF5B under PA
stress contributed to damaged-mitochondria ROS-producing
NLRP3 dependent inﬂammasome activation and later on insulin
resistance in LPS primed macrophage cell model. Similar conclu-
sions have also been drawn from other studies in both cell lines
[10] and animals [1] that mitophagy dysfunction contributes to the
inﬂammasome activation and later on etiology of T2D.
ROS has been shown to activate the NLRP3 inﬂammasome
upon treatment with fatty acids, leading to the release of active IL-
1β and production of IL-1-dependent cytokines and chemokines
[3,8,22–34]. Consistent with these previous studies, our ﬁndings
showed that PA treatment induced damaged-mitochondrial ROS
generation in LPS primed macrophage cells. These efforts led to an
increased expression of cytokines IL-18, IL-1β without affecting
TNF-α, IL-6 expression, which was prevented by antioxidant APDC
or Ca2þ signaling inhibitor Nifedipine. In addition, we provided
several lines of evidence showing that mitophagy was damaged
under metabolic stress. First, we demonstrated that increased
mitochondrial metabolic stress accompanied decreased mitochon-
drial degradation. Second, we showed that this degradation
occurred through the formation of autophagosomes that tethered
and eliminated damaged mitochondria. Finally, mitochondrial
damage characterized by robust mito-ROS production and loss of
membrane potential linked to NLRP3 inﬂammasome activation,
and manipulations that blocked any of these processes reduced
inﬂammasome activation. In sum, our data suggested that this
identiﬁed PA-ROS-NLRP3 pathway was strongly associated with
mitophagy function. In agreement with previous report that HFG-
induced proinﬂammatory responses, which then ultimately
resulted in insulin resistance [4], our ﬁndings conﬁrmed that PA
led to inﬂammasome activation interfering with insulin signaling
pathway, and inhibition of this pathway with siRheb, siKIF5B
aggravated insulin impairment by PA.
Mitophagy has been mainly regarded as an acute degradation
process that is triggered by local and severe mitochondrial
damages under pathological conditions [35,36] or as part of a
developmental process for the removal of excess mitochondria
under physiological conditions [36,37]. The protein Rheb enriched
in brain is a Ras-like small GTPase. Rheb binds GTP after stimula-
tion by nutrients such as amino acids and glucose, and is regulated
by insulin [38]. Rheb has been found recruited to the mitochon-
drial outer membrane upon metabolic stress and regulates mito-
chondrial energetic status-induced mitophagy [16]. In congruent
with these data, our results indicated that PA-induced mitophagy
deﬁciency was driven by Rheb decreased expression and disas-
sociation from mitochondria. In Rheb KO mouse models, Rheb
knockdown led to a strong accumulation of mitochondria in liver
without a rise of mitochondrial activity, suggesting a pathological
situation. Mouse model overexpressing Rheb in beta-cells showed
increased beta-cell size and improved glucose tolerance with
higher insulin secretion and prevention of hyperglycemia [39],
consistent with our study. Given that Rheb plays an important role
in Rheb-dependent mitophagy contributions to the maintenance
of optimal mitochondrial energy production, our data combined
with others demonstrate that altered mitophagy regulation
damages mitochondria dynamic in beta-cells in response to
sustained PA, and in a consequence, may integrate proinﬂamma-
tory responses.
Kinesin superfamily protein KIF5B, is the molecular motor
conveying cargos along microtubules, known to be involved in
mitochondrial movement. The resultant rise in cytosolic Ca2þ
concentration in response to PA primarily triggering insulin
exocytosis [40,41] was also found to regulate mitochondrial move-
ments [17,42,43]. This regulation of mitochondrial dynamics is
Ca2þ-dependent effects on the KIF5B in pancreatic beta cells
[44,45]. Miro1 has been showed to participate in this process by
linking mitochondria to KIF5B motor protein, which was regulated
by changes of Ca2þ concentrations. Elevated Ca2þ concentration
causes the Miro1 to lose its association with microtubules [17,46].
This was consistent with our results that KIF5B was disassociated
from mitochondria and distributed throughout the cytoplasm
macrophage cell under PA-induced increase of Ca2þ condition.
Given that KIF5B is known to be essential for mitochondrial
transport in mammalian cells, loss of this KIF5B-dependent trans-
port pathway enhances mitochondrial fragmentation and follow-
ing depletion of damaged mitochondria under conditions of PA
stress before mitophagy damaged.
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Mitophagy in conjunction with mitochondrial biogenesis, reg-
ulates the changes in steady-state mitochondrial number that is
required to meet metabolic demand under PA stress. Damaged
mitochondria are selectively removed by mitophagy to maintain
quality control. Defective autophagic machinery operated through
Rheb and KIF5B-mediated pathway thereby resulted in proinﬂam-
matory responses and subsequently, damaged insulin secretion.
Recent ﬁndings indicate that Ca2þ is a key molecular regulator of
the NLRP3 inﬂammasome that has critical roles in the pathogen-
esis of auto-inﬂammatory disease [47]. Yet how the Ca2þ as an
important regulator of mitophagy under PA stress needs to be fully
elucidated in the future. Thorough understanding of mitophagy
alterations under PA stress is signiﬁcant towards development of
better therapies to combat inﬂammatory malignancies in T2D.
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